Skip to main content

Find a Clinical Trial

Filter

Showing 1 - 9 out of 9
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
medical-cross
Bladder cancer
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Cancer Center
Learn more
Assist
medical-cross
Chronic kidney disease
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
VX19-NEN-801
medical-cross
Chronic kidney disease, Glomerular disease, Kidney diseases, Proteinuria
user
All genders
person-wave 12-65
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
AMPLITUDE
medical-cross
Chronic kidney disease, Nephropathy, Proteinuria
user
All genders
person-wave 18-65
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
CKD Registry
medical-cross
Chronic kidney disease
user
All genders
person-wave 18-100
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
Cognitive Impairment in HD patients
medical-cross
Hemodialysis access
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
Patient participation to donate blood for laboratory analysis
medical-cross
Nephropathy
user
All genders
person-wave 18-75
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
Jump back to top